Cargando…
Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
The severity of bloodstream infections (BSI) depends on pathogen, source, and host factors. Secretory leukocyte protease inhibitor (SLPI) counteracts tissue damage, balances inflammation, and is increased in pneumonia and sepsis. We aimed to evaluate whether SLPI production differs depending on etio...
Autores principales: | Lange, Anna, Cajander, Sara, Magnuson, Anders, Sundén-Cullberg, Jonas, Strålin, Kristoffer, Hultgren, Olof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647850/ https://www.ncbi.nlm.nih.gov/pubmed/31089838 http://dx.doi.org/10.1007/s10096-019-03567-2 |
Ejemplares similares
-
Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis
por: Lange, Anna, et al.
Publicado: (2022) -
Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
por: Lange, Anna, et al.
Publicado: (2017) -
Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection
por: Cajander, Sara, et al.
Publicado: (2018) -
Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021) -
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)